Oncoinvent ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-140.2	-143.62	-106.28
Depreciation & Amortization	14.56	11.26	7.99
Stock-Based Compensation	-2.19	4.41	-4.44
Other Operating Activities	-0.9	-5.74	6.85
Change in Accounts Payable	23.6	4.69	8.26
Change in Other Net Operating Assets	17.19	-9.11	-1.56
Operating Cash Flow	-87.94	-138.11	-89.19
Capital Expenditures	-1.8	-26.83	-3.98
Sale of Property, Plant & Equipment	0.77	-	-
Other Investing Activities	1.34	4.41	-
Investing Cash Flow	0.31	-22.42	-3.98
Long-Term Debt Repaid	-4.11	-3.53	-3.08
Net Debt Issued (Repaid)	-4.11	-3.53	-3.08
Issuance of Common Stock	207.99	0.51	0.25
Other Financing Activities	-12.66	-0.34	-0.09
Financing Cash Flow	191.21	-3.37	-2.93
Miscellaneous Cash Flow Adjustments	-	-	0.09
Net Cash Flow	103.57	-163.9	-96.01
Free Cash Flow	-89.75	-164.94	-93.17
Free Cash Flow Margin	-1107.55%	-2848.72%	-1482.94%
Free Cash Flow Per Share	-0.97	-8.48	-4.80
Cash Interest Paid	0.08	0.34	0.09
Levered Free Cash Flow	-36.83	-110.11	-
Unlevered Free Cash Flow	-36.78	-110.1	-
Change in Net Working Capital	-40.79	7.82	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.